In cardiac surgery, effective bleeding management is essential for procedural safety and optimal clinical outcomes. Surgical hemostatic agents are commonly used in cardiac surgery as adjuncts to conventional techniques, such as sutures, ligatures, and electrocautery, particularly in situations where these methods alone may be insufficient to achieve hemostasis. Within this context, STARSIL HEMOSTAT® is an absorbable hemostatic powder intended to support the control of bleeding, including diffuse or oozing bleeding, during complex cardiac procedures..

Adjunctive hemostasis in critical surgical settings

Cardiac procedures frequently involve highly vascularized and delicate tissues, where precise bleeding control is required. STARSIL HEMOSTAT® is designed to be applied locally as an adjunct to standard surgical techniques when conventional measures are impractical or ineffective. Its mode of action supports the body’s natural coagulation processes by providing a surface that promotes clot formation. This can be particularly relevant in managing capillary, venous, and small arterial oozing bleeding, where rapid and safe bleeding control is clinically important.

Support of intraoperative workflow

Every minute in the operating room counts, especially during heart surgery. When used alongside established techniques such as suturing, STARSIL HEMOSTAT® may assist in achieving hemostasis more efficiently in certain surgical situations. By supporting localized bleeding control, it can help reduce the need for repeated mechanical interventions in areas where access is limited or tissue is fragile.

Reduced postoperative complications

Blood loss and re-bleeding after cardiac surgery often lead to complications such as secondary hemorrhage, infections, or prolonged ICU stays. The use of an effective medical hemostat like STARSIL HEMOSTAT® helps minimize these risks by supporting stable hemostasis that remains reliable during the critical postoperative phase. This not only improves clinical outcomes but can also shorten recovery time and reduce overall hospital length of stay.

Tissue preservation and improved wound healing

Modern hemostats like STARSIL HEMOSTAT® are designed to be tissue-friendly and do not interfere with the natural healing process. STARSIL HEMOSTAT® particles rapidly absorb fluid from the blood and accelerate the natural coagulation cascade. It forms a dense gel matrix that seals the wound, inhibiting further blood flow. STARSIL HEMOSTAT® is absorbed without residues within 2 to 3 days through endogenous amylase, preventing foreign body reactions or granuloma formation. This supports better wound healing, and overall improved regeneration.

Increased safety for patients with coagulation disorders

Patients undergoing cardiac surgery often present with coagulation disorders or are on anticoagulant therapy, making bleeding control particularly challenging. STARSIL HEMOSTAT® provides an additional layer of safety by remaining effective even under compromised coagulation conditions, recognizing that it does not replace systemic management of coagulation.

Conclusion

In modern cardiac surgery, the choice of hemostatic agent has a direct impact on surgical success. STARSIL HEMOSTAT® stands out as a reliable and efficient solution, supporting rapid bleeding control, including oozing bleeding, in situations where standard methods alone may not be sufficient. While various medical hemostat products exist on the market, STARSIL HEMOSTAT® offers a combination of usability, and clinical reliability that makes it particularly well-suited for the demands of cardiac surgery.